The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Perry Andrew since 2023.
This trader's CIK number is 1877793.
At the time of last reporting, Perry Andrew was the Chief Commercial Officer of G1 Therapeutics, Inc.. (stock ticker symbol GTHX).
Also see all insider trading activities at G1 Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | GTHX | 0 | $0 | 3,750 | $10,879 | 0 | $0 |
| 2023 | GTHX | 0 | $0 | 1,175 | $5,443 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-05 | GTHX | Sale | 1,337 | 2.51 | 3,353 |
| 2024-01-03 | GTHX | Sale | 2,413 | 3.12 | 7,526 |
| 2023-07-05 | GTHX | Sale | 355 | 2.45 | 871 |
| 2023-01-04 | GTHX | Sale | 820 | 5.58 | 4,572 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Perry Andrew (Chief Commercial Officer of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.